Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS
NCT ID: NCT01272882
Last Updated: 2017-05-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2010-05-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE:
The purpose of this pilot study is to examine the feasibility of using the EIT monitor in intensive care unit (ICU) setting on patients with acute respiratory failure and to compare the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT monitor, when applied to adults in acute respiratory failure, will correlate with conventional standard of care assessments for these patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrical Impedance Tomography for Optimization of Positive End-Expiratory Pressure: Acute Respiratory Distress Syndrome
NCT03793842
Pressure Opening With Electrical Impedance Tomography
NCT05825534
Electrical Impendance Tomography Usage in ICU
NCT07184580
Electrical Impedance Tomography for Quantification of Pulmonary Edema in Acute Respiratory Distress Syndrome Patients
NCT02870894
Impact of Belt Position on the Results of PEEP Titration by EIT During ARDS
NCT06541522
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Electrical impedance tomography (EIT) monitoring has been researched as a method to determine the spatial impedance distribution in a body cross section, but has yet to become an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of both global and regional ventilation. Recently, there has been evidence that EIT monitoring has great potential to become a non-invasive bedside tool for assessment of regional lung ventilation without documented hazards. Potential applications include any adult patients in acute respiratory failure. Data collected from this research may contribute to improved patient safety outcomes.
PURPOSE:
The purpose of this pilot study is to examine the feasibility of using the EIT monitor in ICU setting on patients with acute respiratory failure and to compare the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT monitor, when applied to adults in acute respiratory failure, will correlate with conventional standard of care assessments for these patients.
METHOD:
This pilot study design will consist of a prospective, blinded evaluation of the EIT monitor for patients with acute lung injury or acute respiratory distress syndrome.
Once a patient has met the inclusion criteria and has signed informed consent:
1. EIT electrode chest band will be applied by trained respiratory care staff. Application includes elastic chest band with 16 electrodes.
2. EIT electrode chest band is connected to the EIT monitor which will be turned on and will monitor and store EIT data.
3. EIT monitoring will take place for 4 to 6 hours, during day shift (7am to 4pm)
4. Patient's may be monitored on three separate days.
No interventions, tests or modifications to the standard of care will occur to patients for this pilot study of EIT monitoring. Clinicians guiding the care of these patients will be blinded to the EIT data. The EIT chest band will be removed if transport of the patient is necessary or if care is needed in the area of the chest band.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults with ARDS or ALI
Adults with PaO2/FiO2 ratio less than 300. Consented patients will be placed on EIT monitor. The only intervention is the addition of Electrical Impedance Tomography monitoring using the Chest belt with 16 electrodes connected to the EIT device. No changes to standard patient care will occur other than collecting EIT monitor data.
Electrical Impedance Tomography monitoring
Chest belt with 16 electrodes connected to the EIT device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrical Impedance Tomography monitoring
Chest belt with 16 electrodes connected to the EIT device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Males and females \> 18 years old (non-pregnant, non-lactating females).
2. Partial pressure of arterial oxygen (PaO2) / Fraction of inspired oxygen (FiO2) ratio \< 300 torr.
3. Signed informed consent has been obtained.
Exclusion Criteria
2. Patients with skin abrasions or wounds in the chest area.
3. Patients receiving dialysis.
4. Patients with pacemakers or paced EKG rhythms.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Christiana Care Health Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John S Emberger, BS
Role: PRINCIPAL_INVESTIGATOR
Christiana Care Health Services
Vinay Maheshwari, MD
Role: PRINCIPAL_INVESTIGATOR
Christiana Care Health Services
Joel M Brown, BS
Role: PRINCIPAL_INVESTIGATOR
Christiana Care Health Services
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christiana Hospital
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DDD# 600788
Identifier Type: OTHER
Identifier Source: secondary_id
CCC#30067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.